Please note: AABB reserves the right to make updates to this program.
Live Program Date: Wednesday, March 20, 2019 - On-Demand Available
Master Program Number: 19EL-414 (see program format numbers below under Registration)
After participating in this educational activity, participants should be able to:
Twenty-one years ago, the Serious Hazards of Transfusion Haemovigilance (SHOT) scheme began in the United Kingdom. It has had a significant impact on transfusion safety. Dr. Bolton-Maggs has served as the Medical Director of SHOT from 2011 to 2018. She will review the background leading to its formation in 1996. In addition, she will describe how haemovigilance has made transfusions safer. However, errors are responsible for more than 80% of incidents and the SHOT scheme has made recommendations and contributed to national guidelines for transfusion practice which have reduced some of the most common errors. Dr. Bolton-Maggs will discuss the importance of the bedside checklist, to prevent wrong transfusions.
|Single Viewer: On-Demand||Register||19EL-414-4035|
|Group Viewing: On-Demand||Register||19EL-414-8035|
AABB designates both the live and on-demand version of this eCast each to be eligible for 1.0 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The number and type of credits awarded for this program (both live and on-demand) was determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.
Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Paula Bolton-Maggs trained at both Cambridge and Oxford Universities and has been a consultant haematologist for 25 years, initially as a paediatric haematologist at Alder Hey Childrens' Hospital in Liverpool and then as a consultant in adult haemostasis and thrombosis at Manchester Royal Infirmary.
In 2011 she was appointed Medical Director of the UK national haemovigilance scheme, Serious Hazards of Transfusion (www.shotuk.org), this post held until she retired in August 2018. Her main research area is Factor XI deficiency. She has had a longstanding interest in both haemostasis and transfusion and has contributed to several national British Society for Haematology guidelines including paediatric transfusion and appropriate use of FFP and cryoprecipitate, guidelines on blood component administration, and guidelines for the use of irradiated components. She has published more than 120 peer-reviewed papers and guidelines and is an honorary senior lecturer at the University of Manchester.